When you start treatment for acute myeloid leukemia (AML), your doctor may tell you that the goal is remission. You've probably heard the word before, and you know it's a good thing. But what exactly ...
AML 3.0 by IDMERIT is redefining what modern anti money laundering software looks like - faster screening, smarter monitoring ...
RegTech platform AML Watcher expands its agentic AML screening stack with TruRisk, now handling the investigative workload that traditional AML case management software leaves to human analysts.
The panel reached ≥97.8% consensus on AML management. The panel agreed to use international risk stratification categories for personalized treatment of AML. The presence of ≥10% blasts for recurrent ...
Acute myeloid leukemia (AML) is a progressive type of cancer that affects your bone marrow and blood cells. Early detection and treatment are important to help increase the chances of survival from ...
SELLAS Life Sciences Group, Inc. has announced significant milestones in its clinical development of cancer therapies. An Independent Data Monitoring Committee will conduct an interim analysis of the ...
Foghorn Therapeutics Inc. FHTX recently announced that the FDA has placed a full clinical hold on the phase I dose escalation study of pipeline candidate FHD-286 in relapsed and/or refractory acute ...
– Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 ...
More of the world’s economy is moving online, and that is underscored by the long list of recent fundings and acquisitions in the digital ID authentication and anti-money laundering (AML) space, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results